Navigation Links
New Tumor Marker May Improve Cancer Detection: Study
Date:10/20/2010

WEDNESDAY, Oct. 20 (HealthDay News) -- A hormone receptor normally confined to the reproductive organs has been detected in malignant tumors in many parts of the body, researchers report.

Researchers from the Mt. Sinai School of Medicine in New York City, working with French government scientists, say this common link may offer a new target for the early diagnosis and treatment of cancer.

They evaluated tumor tissue samples from 1,336 men and women with 11 common cancers, including prostate, breast, colon, pancreatic, lung, liver and ovarian. The analyses revealed the presence of the follicle-stimulating hormone (FSH) receptor in the blood vessel cells of the tumors.

This receptor is not found on blood vessels in normal tissue, with the exception of the reproductive organs, where it is present in much lower concentrations than in tumors, said the American and French researchers. (In women, FSH, which interacts with the FSH-receptor, normally helps control the menstrual cycle and egg production; in men, FSH normally helps control the production of sperm.)

Activating the FSH receptor contributes to the signaling of a protein (VEGF) that stimulates the growth of blood vessels, including those in tumors. Blocking the action of the FSH receptor may also block the signaling of VEGF.

"This new tumor marker may be used to improve cancer detection," study lead author Aurelian Radu, an assistant professor of developmental and regenerative biology at Mount Sinai School of Medicine, said in a Mount Sinai Medical Center news release.

"Tumor imaging agents that bind to the new marker could be injected in the [body's blood vessel system] and would make visible early tumors located anywhere in the body using magnetic resonance imaging, positron emission tomography, or ultrasound imaging," Radu explained.

In addition, new treatments "can be developed that will block the tumor blood supply, either by inhibiting fo
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Girls with ovarian germ-cell tumors can safely skip chemotherapy unless disease recurs
2. Removing 2mm around breast cancer tumors prevents residual disease in 98 percent of patients
3. Mayo Clinic finds early success with laser that destroys tumors with heat
4. Phase III study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors
5. Experimental Drug Aids Kids With Nervous System Tumor
6. Circulating tumor cells can provide real-time information on patients current disease state
7. Individual mutations are very slow to promote tumor growth
8. VCU study: Researchers discover a drug combination that shrinks tumors in vivo
9. University Hospitals Case Medical Center implements AutoLITT system for treatment of brain tumors
10. Selective inhibition of BMK1 suppresses tumor growth
11. Exosomal release of beta-catenin may explain why CD82 and CD9 suppress tumor metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Tumor Marker May Improve Cancer Detection: Study
(Date:8/28/2014)... with nasal septum cells. Researchers at the University and ... from the nasal septum are able to adapt to ... repair articular cartilage defects. The nasal cartilage cells, ability ... associated with the expression of so-called HOX genes. The ... the research results together with the report of the ...
(Date:8/28/2014)... working out how to safely increase the radiotherapy dose ... local control and survival. , Standard treatment for locally ... radiotherapy and chemotherapy. Traditionally this is planned in a ... be enough to stop tumour growth. , The potential ... varies between patients and depends on the size and ...
(Date:8/28/2014)... 28, 2014 Parker Waichman LLP, a ... years fighting to ensure that the heroes of 9/11 ... coverage to WTC victims who developed 9/11-related cancer was ... Accountability Office (GAO). According to a statement issued by ... report is entitled “World Trade Center Health Program: Approach ...
(Date:8/28/2014)... By Steven Reinberg ... -- Treating pre-cancerous skin spots with a type of light ... freezing the lesions with liquid nitrogen, a new study suggests. ... on the scalp and face of people with fair complexions ... review of prior research found that people who underwent the ...
(Date:8/28/2014)... Alexandria, VA (PRWEB) August 28, 2014 ... Foundation) will interview Stephen Isaacs, the chairperson, president and ... the Foundation’s Meet the Mesothelioma Experts live ... Foundation’s executive director and mesothelioma expert nurse practitioner, ... the interview will be Aduro BioTech’s experimental therapy for ...
Breaking Medicine News(10 mins):Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 3Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3
... 22 Although Attention Deficit ... as only affecting children, for nearly 9 million adults ... reality. According to the National Institutes of Mental Health, ... to a job, remembering or keeping appointments and being ...
... Earn Decision Resources, Clinical Gold Standard Status for ... Report from Decision ResourcesWALTHAM, Mass., April 22 ... and advisory firms for pharmaceutical and healthcare issues, ... on overall survival as the attribute that most ...
... -- Drug side effects are a major problem,for the ... can warrant,drug withdrawal. Unfortunately, these problems often emerge only ... millions of patients. , Identifying ... the,clinic is a major focus of ReproCELL. Current cardiotoxicity ...
... New Plan Designs Help Employers and Their Employees Manage ... Life Insurance Company of America (Guardian), one of the ... employee and voluntary benefits for small and mid-sized companies, ... lineup that will broaden access to more affordable dental ...
... April 22 Celator Pharmaceuticals today ... CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in consolidation treatment for ... in combination with biological agents for the treatment ... Annual Meeting of the American Association for Cancer ...
... 22 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS) ... Sanja Pekovic provided updates from a recent medical ... Gesellschaft - Nederlandse Anatomen Vereniging, Antwerpen, 27-30 March ... of recent positive testing being conducted related to ...
Cached Medicine News:Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 2Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 3Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 4Health News:Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page 5Health News:Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer 2Health News:Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer 3Health News:New Stem Cell Technology to Improve Drug Safety 2Health News:Guardian Adds New Cost-Conscious Options to Group Dental Lineup 2Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 2Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 3Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 2Health News:Hard To Treat Diseases (HTDS) Slavica BioChem Update on Research Activities 3
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate Ebola ... Gambia and Mali ... trials of potential vaccines aimed at preventing the disease that has ... West Africa . Human trials of this ... (NIH) and GlaxoSmithKline, are to be accelerated with funding from an ...
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, ... leader in noninvasive medical monitoring, today announced that the ... Model 3231 OEM/eHealth finger pulse oximeter for use in ... pulse oximeter plugs into a telemedicine hub or kiosk ... pulse rate in pediatric to adult patients. The Model ...
(Date:8/28/2014)... , Aug. 28, 2014   Edison ... today announced a worldwide search for product ideas ... senior population.  Promising ideas uncovered through the 6-month ... leading medical device manufacturers and healthcare retailers with ... the lives of individuals age 65 and older. ...
Breaking Medicine Technology:Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... Neurologics Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., today announced ... ® (topiramate) 100mg Tablets.  These two lots ... in the U.S. and Puerto Rico.  While the ... , the company believes there are fewer than ...
... (Nasdaq: CDXS ) today announced the company will ... 2011 at 4:30 p.m. Eastern Time to discuss its first ... 2011.  The call and webcast will follow the release of ... of the call will be available approximately one hour after ...
Cached Medicine Technology:Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 2Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 3Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 4Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX® 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: